A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP ANALGESIC EFFICACY TRIAL OF ORAL ARRY-371797 IN SUBJECTS UNDERGOING THIRD MOLAR EXTRACTION
Latest Information Update: 22 Feb 2021
Price :
$35 *
At a glance
- Drugs Emprumapimod (Primary)
- Indications Dental pain; Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Array BioPharma; Pfizer
- 08 May 2008 Primary and secondary endpoints achieved; data presented at APA 2008.
- 06 May 2008 Results will be reported at the APA 2008 according to a media release from Array.
- 10 Mar 2008 Status changed from in progress to completed.